Page 4 - ஒன்று ஆய்வகங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒன்று ஆய்வகங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒன்று ஆய்வகங்கள் Today - Breaking & Trending Today

Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M

The
Multidisciplinary Association for Psychedelic Studies released the results from its Phase 3 trial on MDMA for the treatment of post-traumatic stress disorder.
The randomized, blinded, Phase 3 trial enrolled 90 patients with severe chronic PTSD who were divided into two groups.
The first group of 46 participants received three sessions of MDMA-assisted talk therapy, while the control group of 44 people received a placebo as well as the same talk therapy.
Results were measured after 18 weeks. Sixty-seven percent of participants in the MDMA-assisted therapy group no longer qualified for a PTSD diagnosis after the MDMA-assisted therapy sessions versus 32% in the placebo group.
Eighty-eight percent of participants from the MDMA group experienced a clinically significant reduction in symptoms versus 60% in the control group. ....

New York , United States , United Kingdom , San Diego , City Of , San Carlos , Los Angeles , Alex Dominguez , Yaron Conforti , Daniel Carcillo , Braxia Scientific Corp , Multidisciplinary Association For Psychedelic , Wesana Health Go Public , Gilgamesh Pharmaceuticals , Canadian Securities Exchange , Champignon Brands Inc , Venture Exchange , Wesana Health Inc , Novamind Inc , Movers Lab , Department Of State Health Services , Core One Labs Inc , Small Pharma Inc , Field Trip Health Ltd , Akome Biotech Ltd , British Columbia Securities Commission ,

REPEAT - World Renowned Physician Joins Core One Labs as

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals. ....

United States , United Kingdom , New Jersey , British Columbia , Sanofi Pasteur , Smith Klein , Joel Shacker , Javeriana University Medical School , Clinical Team Leader , Colombian Infectious Disease Society , Core One Labs Inc , Infectious Disease Expert At Novartis Pharmaceuticals , Akome Biotech Ltd , Malaria Vaccine Initiative In Bethesda , Health Canada , Infectious Diseases At University Of Toronto , Canadian Securities Exchange , Company Or Core , Vp Clinical Affairs At Fio Corporation , One Labs , Santiago Ferro , Chief Executive Officer , Akome Biotech , Chief Medical Officer , Internal Medicine , Infectious Diseases ,

REPEAT - World Renowned Physician Joins Core One Labs as Chief Medical Officer

REPEAT - World Renowned Physician Joins Core One Labs as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , New Jersey , British Columbia , Sanofi Pasteur , Smith Klein , Joel Shacker , Javeriana University Medical School , Clinical Team Leader , Colombian Infectious Disease Society , Core One Labs Inc , Infectious Disease Expert At Novartis Pharmaceuticals , Akome Biotech Ltd , Malaria Vaccine Initiative In Bethesda , Health Canada , Infectious Diseases At University Of Toronto , Canadian Securities Exchange , Company Or Core , Vp Clinical Affairs At Fio Corporation , One Labs , Santiago Ferro , Chief Executive Officer , Akome Biotech , Chief Medical Officer , Internal Medicine , Infectious Diseases ,

World Renowned Physician Joins Core One Labs as Chief

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals. ....

United States , United Kingdom , New Jersey , British Columbia , Sanofi Pasteur , Smith Klein , Joel Shacker , Javeriana University Medical School , Clinical Team Leader , Colombian Infectious Disease Society , Core One Labs Inc , Infectious Disease Expert At Novartis Pharmaceuticals , Akome Biotech Ltd , Malaria Vaccine Initiative In Bethesda , Health Canada , Infectious Diseases At University Of Toronto , Canadian Securities Exchange , Company Or Core , Vp Clinical Affairs At Fio Corporation , One Labs , Santiago Ferro , Chief Executive Officer , Akome Biotech , Chief Medical Officer , Internal Medicine , Infectious Diseases ,

World Renowned Physician Joins Core One Labs as Chief Medical Officer

Published: May 05, 2021
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals. ....

United States , United Kingdom , New Jersey , British Columbia , Sanofi Pasteur , Smith Klein , Joel Shacker , Javeriana University Medical School , Clinical Team Leader , Colombian Infectious Disease Society , Core One Labs Inc , Infectious Disease Expert At Novartis Pharmaceuticals , Akome Biotech Ltd , Malaria Vaccine Initiative In Bethesda , Health Canada , Infectious Diseases At University Of Toronto , Canadian Securities Exchange , Company Or Core , Vp Clinical Affairs At Fio Corporation , One Labs , Santiago Ferro , Chief Executive Officer , Akome Biotech , Chief Medical Officer , Internal Medicine , Infectious Diseases ,